PHK
CSTL icon

Point72 Hong Kong’s Castle Biosciences CSTL Stock Holding History

Point72 Hong Kong’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,168
Closed -$30K – 432
2022
Q3 		$30K Buy
1,168
+1,042
+827% +$29.2K ﹤0.01% 1551
2022
Q2 		$3K Buy
+126
New +$2.93K ﹤0.01% 1760
2020
Q3 		– Sell
-649
Closed -$24K – 1250
2020
Q2 		$24K Buy
649
+290
+81% +$9.91K ﹤0.01% 859
2020
Q1 		$11K Buy
+359
New +$10.8K ﹤0.01% 659

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Hong Kong's CSTL Position: Q4 2022 in Review

Point72 Hong Kong sold out of Castle Biosciences (CSTL) in Q4 2022, closing a stake of 1,168 shares — an estimated $30K sold.

Point72 Hong Kong first reported a position in CSTL in Q1 2020 and held it in 4 quarters. The position peaked at $30K in Q3 2022. 153 funds tracked by Wall St. Rank hold CSTL as of Q4 2022.

  • Point72 Hong Kong reported no remaining Castle Biosciences position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 1,168 Castle Biosciences shares in Q4 2022, an estimated $30K.
  • Point72 Hong Kong first reported a position in Castle Biosciences in Q1 2020 and held it in 4 quarters.
  • Point72 Hong Kong's Castle Biosciences position peaked at $30K in Q3 2022.
  • 153 funds tracked by Wall St. Rank held Castle Biosciences as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.